{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T22:23:19Z","timestamp":1774045399899,"version":"3.50.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2016,8,5]],"date-time":"2016-08-05T00:00:00Z","timestamp":1470355200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"The German Federal Ministry of Education and Research (Bundesministerium f\u00fcr Bildung und Forschung)","award":["01EO0803 and 01GM1111B."],"award-info":[{"award-number":["01EO0803 and 01GM1111B."]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s10875-016-0320-3","type":"journal-article","created":{"date-parts":[[2016,8,5]],"date-time":"2016-08-05T07:22:42Z","timestamp":1470381762000},"page":"733-738","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["X-linked Inhibitor of Apoptosis Complicated by Granulomatous Lymphocytic Interstitial Lung Disease (GLILD) and Granulomatous Hepatitis"],"prefix":"10.1007","volume":"36","author":[{"given":"Cathal L.","family":"Steele","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Dor\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Ammann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurice","family":"Loughrey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angeles","family":"Montero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siobhan O.","family":"Burns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma C.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bobby","family":"Gaspar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly","family":"Gilmour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahnaz","family":"Bibi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiba","family":"Shendi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Devlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carsten","family":"Speckmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"Edgar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,8,5]]},"reference":[{"issue":"7115","key":"320_CR1","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature05257","volume":"444","author":"S Rigaud","year":"2006","unstructured":"Rigaud S, Fondaneche MC, Lambert N, Pasquier B, Mateo V, Soulas P, et al. XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome. Nature. 2006;444(7115):110\u20134.","journal-title":"Nature"},{"issue":"7","key":"320_CR2","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1182\/blood-2010-01-256099","volume":"116","author":"RA Marsh","year":"2010","unstructured":"Marsh RA, Madden L, Kitchen BJ, Mody R, McClimon B, Jordan MB, et al. XIAP deficiency: a unique primary immunodeficiency best classified as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative disease. Blood. 2010;116(7):1079\u201382.","journal-title":"Blood"},{"key":"320_CR3","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.semcdb.2015.01.015","volume":"39","author":"S Latour","year":"2015","unstructured":"Latour S, Aguilar C. XIAP deficiency syndrome in humans. Semin Cell Dev Biol. 2015;39:115\u201323.","journal-title":"Semin Cell Dev Biol"},{"key":"320_CR4","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s10875-015-0166-0","volume":"35","author":"M Dziadzio","year":"2015","unstructured":"Dziadzio M, Ammann S, Canning C, Boyle F, Hassan A, Cale C, et al. Symptomatic males and female carriers in a large Caucasian kindred with XIAP deficiency. J Clin Immunol. 2015;35:439\u201344.","journal-title":"J Clin Immunol"},{"issue":"1","key":"320_CR5","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.clim.2013.07.004","volume":"149","author":"C Speckmann","year":"2013","unstructured":"Speckmann C, Lehmberg K, Albert MH, Damgaard RB, Fritsch M, Gyrd-Hansen M, et al. X-linked inhibitor of apoptosis (XIAP) deficiency: the spectrum of presenting manifestations beyond hemophagocytic lymphohistiocytosis. Clin Immunol. 2013;149(1):133\u201341.","journal-title":"Clin Immunol"},{"issue":"6","key":"320_CR6","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrm830","volume":"3","author":"GS Salvesen","year":"2002","unstructured":"Salvesen GS, Duckett CS. IAP proteins: blocking the road to death\u2019s door. Nat Rev Mol Cell Biol. 2002;3(6):401\u201310.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"320_CR7","doi-asserted-by":"crossref","first-page":"514","DOI":"10.4049\/jimmunol.179.1.514","volume":"179","author":"JH Park","year":"2007","unstructured":"Park JH, Kim YG, Shaw M, Kanneganti TD, Fujimoto Y, Fukase K, et al. Nod1\/RICK and TLR signaling regulate chemokine and antimicrobial innate immune responses in mesothelial cells. J Immunol. 2007;179(1):514\u201321.","journal-title":"J Immunol"},{"issue":"2","key":"320_CR8","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/sj.emboj.7601962","volume":"27","author":"M Hasegawa","year":"2008","unstructured":"Hasegawa M, Fujimoto Y, Lucas PC, Nakano H, Fukase K, Nunez G, et al. A critical role of RICK\/RIP2 polyubiquitination in Nod-induced NF-kappaB activation. EMBO J. 2008;27(2):373\u201383.","journal-title":"EMBO J"},{"issue":"2","key":"320_CR9","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jaci.2004.05.057","volume":"114","author":"CA Bates","year":"2004","unstructured":"Bates CA, Ellison MC, Lynch DA, Cool CD, Brown KK, Routes JM. Granulomatous-lymphocytic lung disease shortens survival in common variable immunodeficiency. J Allergy Clin Immunol. 2004;114(2):415\u201321.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"320_CR10","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jaci.2015.09.025","volume":"137","author":"L Gamez-Diaz","year":"2016","unstructured":"Gamez-Diaz L, August D, Stepensky P, Revel-Vilk S, Seidel MG, Noriko M, et al. The extended phenotype of LPS-responsive beige-like anchor protein (LRBA) deficiency. J Allergy Clin Immunol. 2016;137(1):223\u201330.","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"320_CR11","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/nm.3746","volume":"20","author":"D Schubert","year":"2014","unstructured":"Schubert D, Bode C, Kenefeck R, Hou TZ, Wing JB, Kennedy A, et al. Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations. Nat Med. 2014;20(12):1410\u20136.","journal-title":"Nat Med"},{"issue":"19","key":"320_CR12","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1056\/NEJMoa073966","volume":"358","author":"C Schuetz","year":"2008","unstructured":"Schuetz C, Huck K, Gudowius S, Megahed M, Feyen O, Hubner B, et al. An immunodeficiency disease with RAG mutations and granulomas. N Engl J Med. 2008;358(19):2030\u20138.","journal-title":"N Engl J Med"},{"issue":"1","key":"320_CR13","first-page":"15","volume":"76","author":"JA Dios De","year":"2012","unstructured":"De Dios JA, Javaid AA, Ballesteros E, Metersky ML. An 18-year-old woman with Kabuki syndrome, immunoglobulin deficiency and granulomatous lymphocytic interstitial lung disease. Conn Med. 2012;76(1):15\u20138.","journal-title":"Conn Med"},{"issue":"1","key":"320_CR14","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s10875-012-9755-3","volume":"33","author":"NM Chase","year":"2013","unstructured":"Chase NM, Verbsky JW, Hintermeyer MK, Waukau JK, Tomita-Mitchell A, Casper JT, et al. Use of combination chemotherapy for treatment of granulomatous and lymphocytic interstitial lung disease (GLILD) in patients with common variable immunodeficiency (CVID). J Clin Immunol. 2013;33(1):30\u20139.","journal-title":"J Clin Immunol"},{"issue":"3","key":"320_CR15","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/cei.12306","volume":"176","author":"S Ammann","year":"2014","unstructured":"Ammann S, Elling R, Gyrd-Hansen M, Duckers G, Bredius R, Burns SO, et al. A new functional assay for the diagnosis of X-linked inhibitor of apoptosis (XIAP) deficiency. Clin Exp Immunol. 2014;176(3):394\u2013400.","journal-title":"Clin Exp Immunol"},{"issue":"12","key":"320_CR16","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1182\/blood-2011-08-374199","volume":"119","author":"YT Bryceson","year":"2012","unstructured":"Bryceson YT, Pende D, Maul-Pavicic A, Gilmour KC, Ufheil H, Vraetz T, et al. A prospective evaluation of degranulation assays in the rapid diagnosis of familial hemophagocytic syndromes. Blood. 2012;119(12):2754\u201363.","journal-title":"Blood"},{"issue":"1","key":"320_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MOP.0b013e32834ea739","volume":"24","author":"DT Teachey","year":"2012","unstructured":"Teachey DT. New advances in the diagnosis and treatment of autoimmune lymphoproliferative syndrome. Curr Opin Pediatr. 2012;24(1):1\u20138.","journal-title":"Curr Opin Pediatr"},{"issue":"6837","key":"320_CR18","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/35079107","volume":"411","author":"JP Hugot","year":"2001","unstructured":"Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn\u2019s disease. Nature. 2001;411(6837):599\u2013603.","journal-title":"Nature"},{"issue":"1","key":"320_CR19","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/imr.12193","volume":"260","author":"W Strober","year":"2014","unstructured":"Strober W, Asano N, Fuss I, Kitani A, Watanabe T. Cellular and molecular mechanisms underlying NOD2 risk-associated polymorphisms in Crohn\u2019s disease. Immunol Rev. 2014;260(1):249\u201360.","journal-title":"Immunol Rev"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-016-0320-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10875-016-0320-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-016-0320-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T20:01:38Z","timestamp":1498334498000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10875-016-0320-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,5]]},"references-count":19,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["320"],"URL":"https:\/\/doi.org\/10.1007\/s10875-016-0320-3","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,5]]}}}